Filing metadata

Accession number
0000950170-25-043849
Form type
Form 4
Filer
Amylyx Pharmaceuticals, Inc.
CIK
CIK 1658551
Filed
Mar 24, 2025
Reporting period
Mar 20, 2025
Description
Insider transaction

Explore SEC Filings Hub